Current adjuvant therapy for breast cancer does not fully leverage the understanding of small population dynamics and the potential to cause cancer cell extinction.

“and I it's a great point because um how do we treat you know ad how do we treat breast cancer with ad therapy well we give them platinum or some you know some drug for some period of time and that's it well why don't we give you know a sequence of drugs why don't we take advantage of because we know for sure we're dealing with small populations and we know for sure that we can we can cause them to go extinct at least some of the time so why don't we optimize how we do this instead of Simply pick up a drug from the shelf and and and administer it continuously you know for 6 months”